Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway
)
By stimulating insulin release and inhibiting glucagon, Tirzepatide helps stabilize blood sugar levels, reducing the risk of hyperglycemia, insulin resistance, and type 2 diabetes
Metformin is often prescribed along with lifestyle modifications, such as adopting a healthy diet and increasing physical activity, to help lower blood glucose levels and improve overall glycemic management
Developed by BioSpecifics Technologies Corporation and marketed as XIAFLEX in the U.S
Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database
Important Safety Information Contraindications and Precautions: Joint injections should only be performed by qualified medical professionals Active joint infection is an absolute contraindication to intra-articular injection Bleeding disorders or anticoagulation therapy may increase injection risks Pregnancy and breastfeeding: no safety data available, avoid use Cancer history: while AOD-9604 does not affect IGF-1, consult oncologist before use Monitoring Recommendations: Regular follow-up with joint imaging and functional assessments to evaluate treatment response
